Search results
Author(s):
Mikhail Kosiborod
Added:
1 year ago
HFSA 24 - We are joined virtually by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss findings from the STEP-HFpEF trial programme in regard to the efficacy of semaglutide according to frailty status, and exercise function at baseline.Interview Questions:1. Could you remind us of the importance of STEP-HFpEF2. What was the study design and patient population?3. What…
View more
Author(s):
Anastasia Shchendrygina
,
Amina Rakisheva
,
Ilya Giverts
,
et al
Added:
1 year ago
Author(s):
Belén Biscotti Rodil
,
Juan Duarte Torres
,
Irene Martín de Miguel
,
et al
Added:
1 month ago
Author(s):
Jan Pec
,
Michael Arzt
Added:
1 month ago
Author(s):
Jonathan Na
,
Miguel Valderrábano
,
Paul Schurmann
Added:
4 weeks ago
Author(s):
Gregory Lewis
Added:
3 months ago
HFSA 25 - Aficamten improves excercise capacity compared to metoprolol in patients with obstructive hypertrophic cardiomyopathy in a prespecified analysis of the MAPLE-HCM study.Dr Gregory Lewis joins us to discuss findings from a prespecified cardiopulmonary exercise testing analysis of the MAPLE-HCM trial, which reveals divergent effects between aficamten and metoprolol on exercise performance…
View more
Author(s):
Sébastien Baillieul
,
Renaud Tamisier
,
Jean-Louis Pépin
Added:
1 month ago
Author(s):
Emily Morris
,
Oliver J Rider
Added:
3 weeks ago
Jamie M O’Driscoll
Job title: Reader in Cardiovascular Physiology
Author
